vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $61.3M, roughly 1.4× Atlanta Braves Holdings, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -67.6%, a 29.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 17.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
BATRA vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $61.3M | $83.1M |
| Net Profit | $-41.4M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | -81.2% | -4.1% |
| Net Margin | -67.6% | -38.1% |
| Revenue YoY | 17.6% | 20.2% |
| Net Profit YoY | -116.7% | -27.9% |
| EPS (diluted) | $-0.64 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $61.3M | $76.4M | ||
| Q3 25 | $311.5M | $83.3M | ||
| Q2 25 | $312.4M | $79.2M | ||
| Q1 25 | $47.2M | $69.2M | ||
| Q4 24 | $52.1M | $68.2M | ||
| Q3 24 | $290.7M | $58.4M | ||
| Q2 24 | $282.9M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-41.4M | $-29.8M | ||
| Q3 25 | $30.0M | $-21.4M | ||
| Q2 25 | $29.5M | $-19.6M | ||
| Q1 25 | $-41.4M | $-24.7M | ||
| Q4 24 | $-19.1M | $-18.9M | ||
| Q3 24 | $10.0M | $-21.0M | ||
| Q2 24 | $29.1M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -81.2% | -40.6% | ||
| Q3 25 | 12.5% | -27.8% | ||
| Q2 25 | 13.4% | -28.0% | ||
| Q1 25 | -94.2% | -39.7% | ||
| Q4 24 | -35.8% | -28.9% | ||
| Q3 24 | 2.2% | -38.4% | ||
| Q2 24 | 8.8% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -67.6% | -39.1% | ||
| Q3 25 | 9.6% | -25.7% | ||
| Q2 25 | 9.4% | -24.7% | ||
| Q1 25 | -87.7% | -35.8% | ||
| Q4 24 | -36.7% | -27.6% | ||
| Q3 24 | 3.4% | -35.9% | ||
| Q2 24 | 10.3% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.64 | $-0.54 | ||
| Q3 25 | $0.47 | $-0.38 | ||
| Q2 25 | $0.46 | $-0.35 | ||
| Q1 25 | $-0.66 | $-0.45 | ||
| Q4 24 | $-0.29 | $-0.34 | ||
| Q3 24 | $0.16 | $-0.40 | ||
| Q2 24 | $0.46 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $245.6M |
| Total DebtLower is stronger | $738.6M | $51.7M |
| Stockholders' EquityBook value | $526.0M | $347.7M |
| Total Assets | $1.6B | $487.1M |
| Debt / EquityLower = less leverage | 1.40× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $99.9M | $286.5M | ||
| Q3 25 | $82.2M | $294.3M | ||
| Q2 25 | $96.2M | $302.7M | ||
| Q1 25 | $244.7M | $316.2M | ||
| Q4 24 | $110.1M | $333.7M | ||
| Q3 24 | $100.9M | $196.8M | ||
| Q2 24 | $121.2M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $738.6M | $51.6M | ||
| Q3 25 | $759.9M | $51.6M | ||
| Q2 25 | $703.1M | $51.5M | ||
| Q1 25 | $699.5M | $51.5M | ||
| Q4 24 | $617.1M | $51.5M | ||
| Q3 24 | $640.1M | $51.4M | ||
| Q2 24 | $600.0M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $526.0M | $365.9M | ||
| Q3 25 | $560.3M | $380.3M | ||
| Q2 25 | $522.8M | $385.8M | ||
| Q1 25 | $486.1M | $389.2M | ||
| Q4 24 | $524.2M | $402.2M | ||
| Q3 24 | $530.4M | $241.2M | ||
| Q2 24 | $512.7M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $1.6B | $508.1M | ||
| Q3 25 | $1.7B | $511.5M | ||
| Q2 25 | $1.7B | $513.1M | ||
| Q1 25 | $1.7B | $519.4M | ||
| Q4 24 | $1.5B | $534.0M | ||
| Q3 24 | $1.6B | $374.1M | ||
| Q2 24 | $1.6B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 1.40× | 0.14× | ||
| Q3 25 | 1.36× | 0.14× | ||
| Q2 25 | 1.34× | 0.13× | ||
| Q1 25 | 1.44× | 0.13× | ||
| Q4 24 | 1.18× | 0.13× | ||
| Q3 24 | 1.21× | 0.21× | ||
| Q2 24 | 1.17× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $26.4M | $-10.3M | ||
| Q3 25 | $-88.8M | $-6.6M | ||
| Q2 25 | $-8.1M | $-15.0M | ||
| Q1 25 | $95.8M | $-17.0M | ||
| Q4 24 | $28.9M | $-32.4M | ||
| Q3 24 | $-69.0M | $-18.8M | ||
| Q2 24 | $-34.3M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | $-82.3M | $-17.8M | ||
| Q1 25 | $76.3M | $-18.8M | ||
| Q4 24 | $16.8M | $-33.6M | ||
| Q3 24 | $-85.5M | $-19.0M | ||
| Q2 24 | $-64.1M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | -26.3% | -22.5% | ||
| Q1 25 | 161.5% | -27.2% | ||
| Q4 24 | 32.3% | -49.2% | ||
| Q3 24 | -29.4% | -32.6% | ||
| Q2 24 | -22.7% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 2.4% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 23.7% | 3.5% | ||
| Q1 25 | 41.3% | 2.7% | ||
| Q4 24 | 23.2% | 1.7% | ||
| Q3 24 | 5.7% | 0.4% | ||
| Q2 24 | 10.5% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | — | ||
| Q2 25 | -0.28× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.89× | — | ||
| Q2 24 | -1.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
